PA-25-424: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

PA-25-424: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Executive summary

PA-25-424 is the 2026 NIH parent fellowship announcement for senior researchers (Parent F33). It is a competitive, mentor-driven fellowship for investigators who already have an established, independent research identity and now need protected time, skills expansion, and structured training support for a career transition or strategic retooling phase.

This NOFO is explicitly for experienced scientists, not early-career postdocs. It supports a sabbatical-like training period under one or more sponsors and is therefore a strong fit for applicants who can clearly show why they need an intentional, mentored step change rather than ordinary project funding.

At-a-glance details

Who this opportunity is for (and who it is not for)

This opportunity is designed for the “mid-career reset” moment that many NIH-funded researchers reach after years of independent work. If your scientific trajectory is strong but you need a concentrated period to acquire a new capability, pivot methods, enter a new field, or build a long-term collaboration base, F33 is built for that shape of career decision.

The NOFO wording is explicit:

• It is for candidates with at least seven years of relevant research or professional experience.
• It is for independent investigators.
• It is usually framed as fellowship support for training and capability expansion.
• It is not designed for postdoctoral-level research training.

In practical terms, this means you should not apply simply because you want general operating funds for an ongoing lab program. You apply when the core product of the award is a training outcome: new methods mastery, major methodological redirection, an emerging field pivot, or a formalized shift in scientific direction that requires sponsor-guided support.

Not a fit if:

• You seek an early-career predoctoral path (F31 style)
• You need an award where you are the independent trial lead of a clinical trial
• You cannot articulate a training gap that a structured fellow-level retooling plan can solve

Program purpose and what NIH says the fellowship should deliver

The announcement describes PA-25-424 as a fellowship to support experienced scientists who want to broaden their research background as independent investigators and align with participating NIH Institute and Center (IC) missions. The intent is not broad project execution and not pure output subsidy. It is explicitly a planned training intervention in service of a future phase of a scientific career.

Three key ideas are visible in the program structure:

1. Research training is central, not peripheral.

   The PHS Fellowship Supplemental Form and Research Training Plan sections are core parts of submission structure. This matters because your application must convince reviewers that the award advances your capacity, not only that your idea is publishable.

2. Mentorship is a compliance and quality requirement, not a formality.

   The sponsor structure (and sponsor team, if used) must be credible. The NOFO requires identifying a sponsor and a training environment before submission.

3. Foreign training is allowed only with evidence of scientific advantage.

   Foreign settings are possible, but only where you can prove they are clearly better for the proposed training than domestic alternatives.

The NOFO does not provide a fixed fixed total award amount in the announcement body because stipend rates and associated components change per NIH fiscal policy and participant role. Instead, it points to the NRSA policy notice pages for current stipend and support values.

Eligibility in practical terms

This section should be treated as your first screening layer before you draft a paragraph.

Required applicant profile

The announcement states an eligible fellow should have at least 7 subsequent years of relevant research or professional experience and be at an independent investigator stage.

Before you proceed, confirm these are true in your own case:

• Have you already reached independent PI-level activity and output consistency?
• Is your fellowship intent to increase capability, not to establish your first independent line of work?
• Can your scientific supervisor ecosystem support a defined retooling sequence with measurable outcomes?

Citizenship and status

The candidate/PD at time of award must be a U.S. citizen, non-citizen national, or lawful permanent resident (Form I-551 path). If your status is changing, resolve this before opening registration and internal deadlines.

Applicant organization eligibility

The program allows a broad range of sponsoring organizations, including:

• public/private higher education institutions,
• nonprofits,
• small businesses and for-profit organizations,
• federal agencies,
• foreign organizations in eligible configurations.

The key qualifier is not just category, but whether the sponsor organization has the practical capacity to deliver the proposed training environment.

Foreign training conditions

A frequent misconception is that foreign training is automatically eligible if an organization is foreign. It is not automatic in practice. The NOFO states foreign training is considered when the applicant shows clear scientific advantage and a strong sponsor fit. If your proposal cannot justify why abroad is scientifically superior, that piece can weaken review.

Registration requirements (hard blockers)

The NOFO is blunt: required registrations must be complete before submission and late registration is not a valid reason for late submission. This includes:

• SAM/NCAGE as applicable,
• UEI registration,
• eRA Commons setup with required roles,
• Grants.gov registration.

In many cases this is where applications stall. If your organization is doing this first time, build registrations into your timeline early. The NOFO itself warns this can take weeks.

Deadlines, cycle behavior, and what “ongoing” means

PA-25-424 is posted and open, with a standard due-date table that continues through 2028. For 2026/2027 planning purposes, the key due dates in the NOFO include:

• 2026-04-08
• 2026-08-08
• 2026-12-08
• 2027-04-08
• 2027-08-08
• 2027-12-08

Those dates are paired with NIH’s review and start-date flow (review ~1–3 months after due date depending on cycle) and with a 5:00 PM local submission deadline.

For operational planning, treat it like this:

• Use one of those cycle dates as a target, not a target for a final manuscript.
• Complete references, institutional forms, and compliance checks well before your chosen due date.
• Build an internal cutoff at least 3–5 days earlier because technical warnings from ASSIST/Grants.gov can require correction.

Because there are recurring standard dates, this is practical for teams that prepare quarterly cycles and prefer batching applications. However, recurring dates are only useful if the underlying IC constraints and training fit remain aligned with your project goals.

Submission architecture and workflow

PA-25-424 uses the standard NIH Fellowship process. In concrete terms, your path should be:

1. Get registrations complete.
2. Obtain and confirm your route: ASSIST vs institutional S2S vs Grants.gov Workspace.
3. Build package around official Fellowship (F) instructions and this NOFO’s additional rules.
4. Keep PD/PI account details clean:
   • eRA Commons account in good standing,
   • required roles set,
   • ORCID linked to the credential profile.
5. Draft all core sections with section-level objectives tied to review criteria.

Recommended application architecture (highly practical)

The NOFO makes it clear the fellowship is not judged only on science novelty. The strongest applications are usually coherent across five linked sections:

1) Candidate section

This is where you establish readiness. For F33 reviewers, you should write progression, not reinvention. Explain clearly what you have done, why you cannot progress to your next stage without structured retraining, and why your current environment supports that.

2) Mentored training plan

This is the intellectual centerpiece. A strong plan in this fellowship should include:

• Baseline skill profile before the fellowship,
• target capability at 6–18 months,
• how the sponsor’s expertise maps to each targeted capability,
• what concrete outputs (not just papers) signal successful retooling.

3) Commitment and environment

Reviewers will check sponsor commitment and institutional fit. State explicitly what support exists: lab space, data infrastructure, mentoring cadence, and project-level resources. Show how these resources support outcomes.

4) Budget logic

F33 budgets are not free-form. NIH expects stipend/tuition/fees and institutional allowance components, with indirect costs handled through institutional allowance rules. Avoid building a budget that sounds like infrastructure-only expansion without a training rationale.

5) Appendix discipline

Appendix space is limited and should be used in line with instructions. Many teams fail by dumping supplemental material that is not required.

Review lens: what review panels actually evaluate

The program review criteria in the NOFO are very practical and can be mapped into a scoring checklist:

• Is the candidate’s training need clearly diagnosed and realistic?
• Is the sponsor arrangement strong, committed, and aligned with each aim?
• Is the environment capable, not just prestigious?
• Is the project design realistic for the requested training period?
• Are human subjects and any clinical-trial-experience components fully compliant and properly supervised?

In short: NIH panels evaluate whether the fellowship materially increases the candidate’s scientific capacity. A technically exciting idea with weak training structure will underperform a more modest idea with strong training logic.

Common mistakes and how to avoid them

Error: treating F33 like an R-series research grant

The strongest mistake is to write as if F33 is simply money for running your current program. The NOFO is clear this is a training award where the candidate trajectory matters as much as project output. Build training architecture first, then scientific output.

Error: incomplete registrations at deadline

The NOFO explicitly says late registration is not valid excuse. If SAM/eRA Commons/Grants.gov setup is not complete, the application can fail administrative screening.

Error: under-specifying mentor role

A named sponsor is required. If using a sponsor team, one sponsor must be primary. If the relationship is vague, reviewers see it as weak mentorship readiness.

Error: weak justification for foreign training

Foreign components are allowed, but only when advantages are scientifically clear and documented. If no clear comparison with domestic options exists, do not over-assert.

Error: ignoring review-level detail in human subjects or clinical-trial participation

Even where a fellow does not lead a clinical trial, clinical-trial-linked experience may still be part of training. In those cases, sponsor oversight, IRB interaction, informed-consent context, and safety responsibilities should be explicit.

Step-by-step prep checklist (48-week style)

12–16 weeks before target submission

• Confirm IC fit against participating NIH IC mission.
• Choose and secure primary sponsor.
• Resolve registration status for all involved institutions and candidate accounts.
• Pull latest NRSA policy notices for stipend and funding tables.

8–10 weeks before

• First full draft of training plan and timeline.
• Draft environment and mentor commitment language.
• Internal legal/compliance check for foreign component (if any).

6 weeks before

• Build budget section tied to NRSA component logic.
• Prepare letters and internal approvals.
• Pre-check in ASSIST/Grants.gov and map correction risks.

3–4 weeks before

• Internal review by a grant writer and a mentor outside the sponsor team.
• Confirm PHS Human Subjects entry and trial-experience compliance statements where applicable.

1 week before

• Final compliance sweep for links, page limits, signature flows, and ORCID in PD/PI profile.

FAQ

Q1: Is this still open in 2026 and 2027?

The NOFO remains active with cycles into 2027 and an expiry into 2028. It is structured as a recurring NIH standard-dates format, so there are multiple filing opportunities.

Q2: Can a for-profit organization apply?

Yes, as described in the eligibility section. But regardless of legal type, the organization must provide a suitable training environment with staff, facilities, and sponsor commitment.

Q3: Can an established investigator apply in a standard postdoctoral discipline?

PA-25-424 is for senior fellows and specifically not for postdoctoral-level investigators. It is for established independent investigators.

Q4: Can I propose a clinical trial as a lead?

No. Independent clinical trials are not allowed. Research experience in a clinical trial led by a sponsor is allowed when properly framed as training.

Q5: Is the award amount fixed?

No single fixed total is in the NOFO page itself. NIH points to annual NRSA notices and policy pages for current stipend and support levels.

Q6: Can there be multiple PD/PI?

The NOFO states multiple PD/PI are not allowed.

Official links and follow-up actions

• Parent NOFO (official source): https://grants.nih.gov/grants/guide/pa-files/PA-25-424.html
• NIH Grants and application policy notices: https://grants.nih.gov/grants/guide
• NIH NRSA page for policy notices and rates: https://researchtraining.nih.gov/resources/policy-notices
• eRA Commons support (application support): https://www.era.nih.gov/need-help
• NIH Grants.gov support: https://www.grants.gov

Final action guidance

If your candidacy is in the “ready-to-pivot” zone, do not treat this as a one-off idea application. Treat it as a career-architecture package:

• justify why your independence now requires a structured training intervention,
• show sponsor and environment fit,
• and submit with enough time for NIH-system corrections.

The Parent F33 path is most valuable when your goal is durable reorientation with evidence of scientific return, not only a near-term publication cycle.